Allianz Asset Management’s Albany Molecular Research Inc AMRI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-442,716
| Closed | -$9.61M | – | 2188 |
|
|
2017
Q2 | $9.61M | Buy |
442,716
+170,385
| +63% | +$3.7M | 0.01% | 991 |
|
|
2017
Q1 | $3.82M | Sell |
272,331
-34,940
| -11% | -$490K | ﹤0.01% | 1279 |
|
|
2016
Q4 | $5.76M | Sell |
307,271
-38,931
| -11% | -$730K | 0.01% | 1177 |
|
|
2016
Q3 | $5.71M | Sell |
346,202
-39,149
| -10% | -$645K | 0.01% | 1165 |
|
|
2016
Q2 | $5.18M | Sell |
385,351
-10,045
| -3% | -$135K | 0.01% | 1126 |
|
|
2016
Q1 | $6.05M | Sell |
395,396
-441,879
| -53% | -$6.76M | 0.01% | 1089 |
|
|
2015
Q4 | $16.6M | Buy |
837,275
+76,469
| +10% | +$1.52M | 0.02% | 726 |
|
|
2015
Q3 | $13.3M | Buy |
760,806
+13,126
| +2% | +$229K | 0.02% | 781 |
|
|
2015
Q2 | $15.1M | Sell |
747,680
-44,593
| -6% | -$902K | 0.02% | 795 |
|
|
2015
Q1 | $13.9M | Sell |
792,273
-122,823
| -13% | -$2.16M | 0.02% | 719 |
|
|
2014
Q4 | $14.9M | Buy |
915,096
+2,819
| +0.3% | +$45.9K | 0.02% | 701 |
|
|
2014
Q3 | $20.1M | Buy |
912,277
+99,153
| +12% | +$2.19M | 0.02% | 600 |
|
|
2014
Q2 | $16.4M | Sell |
813,124
-70,280
| -8% | -$1.41M | 0.02% | 611 |
|
|
2014
Q1 | $16.4M | Buy |
883,404
+76,806
| +10% | +$1.43M | 0.02% | 599 |
|
|
2013
Q4 | $8.13M | Buy |
806,598
+6,788
| +0.8% | +$68.4K | 0.01% | 797 |
|
|
2013
Q3 | $10.3M | Sell |
799,810
-22,475
| -3% | -$290K | 0.01% | 647 |
|
|
2013
Q2 | $9.76M | Buy |
+822,285
| New | +$9.76M | 0.01% | 636 |
|